Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Price, MD
DexCom, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Amcr
Escondido, California, United States
- William Sansum Diabetes Center
Santa Barbara, California, United States
- Diablo Clinical Research
Walnut Creek, California, United States
- Rainier Clinical Research Center Inc
Renton, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Feb 2017
- Primary completion
- 4 Mar 2017
- Completion
- 4 Mar 2017
- Last update posted
- 31 Dec 2018
- Registered enrollment
- 70
- Registry id
- NCT03087877
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.